Lancet paper on Hydroxychloroquine with questionable data; WHO suspends HCQ trial

The Lancet, one of the world’s oldest and best-known general medical journals, published a research paper on Hydroxychloroquine with questionable data according to French Professor Didier Raoult, who is also the director of IHU Méditerranée Infection.

More and more people have noticed since the start of the pandemic that the Lancet has been publishing research papers without solid peer reviews as long as the conclusion is in accordance with the World Health Organization (WHO).

WHO and Bill & Melinda Gates Foundation are among the organizations that provide funding to the Lancet.

WHO Suspends Hydroxychloroquine Treatment in COVID-19 Solidarity Trial based on the Lancet Paper

In an announcement made by WHO Director-General Dr. Tedros Adhanom Ghebreyesus on Monday, the global organization suspends HCQ trial citing data published by The Lancet on Friday, May 22, which showed autoimmune therapies hydroxychloroquine or chloroquine—with or without a macrolide—did not conclusively show in-hospital outcome benefits.

Professor Didier Raoult’s tweet about questionable data in the Lancet paper

Peak Prosperity’s explanation of HCQ data in layman’s terms

Here is the link to the Lancet Paper on Hydroxychloroquine:

Inline Feedbacks
View all comments

Popular Articles


May. 28, 2020